Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant diseaseRebecca Smith, James E. Korkola|Scientific Reports|2020Cited by 74
Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneitySheng‐Jia Lin, Gaurav K. Varshney, Tracy Lau et al.|Genome Medicine|2023Cited by 14